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 Abstract 
With many individuals experiencing multimorbidity, individuals are being prescribed 
more medications.  Although there are benefits to taking medications to manage 
symptoms and treat disease processes, there are also risks to taking multiple medications. 
The purpose of this phenomenological study was to explore participants’ understanding 
of the risks associated with practicing polypharmacy. Game theory, credibility theory, 
and belief bias were the conceptual frameworks used to explain how individuals 
experienced their care and being prescribed 5 or more medications. Eight participants 
residing in subsidized housing in a small Midwest city, who were taking 5 or more 
medications volunteered to take part in semi-structured interviews answering a series of 
10 questions.  Phenomenological analysis was used to organize the data and to assist with 
the development of themes regarding the nature of the participants’ lived experiences. 
According to study findings, 7 out of 8 participants stated that they trusted their providers 
and that their providers used a more directive approach to prescribing medications instead 
of offering choices to the participants. In addition, participants lacked knowledge of the 
risks associated with taking all medications collectively, indicating that more education is 
needed for individuals. Results of the study may be used in both provider training and 
patient training to stimulate social change that may improve provider patient 
communication, increase understanding of provider patient interactions, elicit positive 
patient outcomes by providing knowledge of awareness, communication, and interaction 
styles, which play a role in patient outcomes. 
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Chapter 1: Introduction to the Study  
Adverse drug events in adults are a health concern in the United States. Annually, 
there are hundreds of thousands of individuals in the United States each year who visit 
hospital emergency rooms as a result of adverse drug events (Center for Disease Control 
[CDC], 2012). Many scholars have focused on elderly individuals and individuals who 
suffer with schizophrenia without focusing on a broader range of individuals between the 
ages of 19-64. The purpose of this study was explore individuals’, ages of 19-64, reported 
complications regarding taking five or more medications. 
In this phenomenological study, I described participants’ perceived understanding 
of their diagnoses and medications prescribed for their diagnoses. I interviewed 
participant who had been prescribed five or more medications. For the purposes of this 
study, I focused on participants’ report of the combination of medications they were 
prescribed, and I asked them to identify if they had experienced any side effects while 
taking medications, how many prescribers they had, and if they had been hospitalized due 
to adverse drug events. By asking the aforementioned questions, I gained a better 
understanding of the individuals’ understanding of their medications, any difficulties 
connected to taking medications, confusion of what medications they were taking, and if 
there had been any negative effects associated with being on five or more medications. 
The study findings may lead to positive social change by addressing the gap of 
knowledge and understanding of the risks associated with taking five or more prescribed 
medications by individuals between the ages of 19-64. This improved understanding 
could lead to awareness, which could lead to change. Individuals could benefit from 
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individual psychopharmacologic education, especially during additions or deletions of 
medications from their medication regimens.  
Background of the Problem 
Few scholars have explored patient medication education within the adult 
population. According to Lenahan, McCarthy, Davis, Curtis, Serper, and Wolf (2013), 
many individuals have difficulty recalling their medications, and individuals who have 
difficulty recalling the name of the medication also cannot identify the pill. These 
individuals have more instances of nonadherence to medication regimens and 
uncontrolled symptoms (Lenahan et al., 2013). The CDC (2012) also identified that 
elderly individuals consume three times the amount of medications as the nonelderly 
individuals. The elderly are taking an average of three to six different medications at a 
time (Maio et al., 2011). An increased number of medications can increase the risk of 
adverse drug events, hospitalizations, and even death (CDC, 2012). Holt, Rung, Leon, 
Firestein, and Krousel-Wood (2014) and Berry et al. (2014) found that the elderly may 
experience forgetfulness and communication misunderstanding, decreasing the adherence 
to medications for individuals. Yasein, Barghouti, Irshaid, and Suleiman (2013) identified 
that two-thirds of individuals did not take their medications properly as prescribed.  
Few scholars have focused on nonelderly adults (ages 19-64) and polypharmacy 
along with the participant’s knowledge of the risks associated with taking five or more 
medications. It is important for individuals to be well informed about their medications 
and combinations of medications and to be comfortable asking their prescriber questions 
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pertaining to the safety and possible interactions of the medications that they are being 
prescribed.  
Statement of the Problem 
In the United States, there have been approximately 700,000 individuals reported to have 
presented to the emergency room due to adverse drug events, with a reported 120,000 of 
those individuals being admitted to the hospital for care; 100,000 deaths were reported 
due to adverse drug events (CDC 2012). Although individuals need medications for their 
multiple illnesses and ailments (including both mental illness and physical illnesses), 
individuals may not understand the medications they are taking; the purpose of taking the 
medications; as well as the potential risks of prescribed medications, risks related to 
combining different medications, and possible side effects associated with the different 
medications that they are taking. According to Sarkar, López, Maselli, and Gonzales 
(2011), between the years of 2005 and 2007, there were a reported 13.5 million adverse 
drug events (ADE) in the combined inpatient and outpatient setting nationally. The 
annual cost of these adverse drug events reportedly ranged from 17 to 29 billion dollars. 
Sarkar et al. reported that 72% of the 13.5 million ADE were from the outpatient setting, 
and 28% reported in the emergency room or other hospital/inpatient setting.  
Purpose of the Study 
The purpose of this study was to understand the level of knowledge that 
community dwelling individuals between the ages of 19 and 64 had regarding taking five 
or more medications in general, side effects of their medications, as well as drug-drug 
interactions. The results of this study can be used to develop more attention on the 
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importance of awareness of knowledge surrounding medications to improve adherence 
and to decrease ADEs.  By hearing about individuals; thoughts, feelings, and knowledge 
associated with taking five or more medications, there can be a better understanding of 
whether or not people need to be more aware of their medications, interactions, and 
adverse effects of being on five or more medications. 
Research Questions 
1. What is the lived experience of adults who are prescribed five or more 
medications?  
2. What is the knowledge of medications and understanding of risks associated with 
medications? 
3. What are the participants’ ability and comfort in asking prescribers questions 
pertaining to their medications?   
Theoretical Framework 
There are many different models of decision making. There are different 
perspectives on the patient-provider relationship and decision making, as well as the 
belief that the patient-provider relationship is important in medical and mental health 
care. For this study, there were four different frameworks that I included: the game 
theory, paternalism versus autonomy in health care, credibility theory, and belief bias. To 
explore participants’ understanding of prescribed medications with multimorbidity, I 
focused on different decision making models as possible contributing factors to 
polypharmacy; individuals’ level of comfort with their care; and asking questions of their 
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provider regarding medications, side effects, and general questions regarding starting or 
stopping their medications.  
 In regard to paternalism versus autonomy in the medical practice and the medical 
provider-patient relationship, Murgic, Hebert, Sovic and Pavlekovic (2015) reported that 
autonomy is ethically essential in the medical field. In addition, Murgic et al. reported 
that patients have more of a choice in their care.  
According to credibility theory (Gass & Seiter 1999), individuals consider 
professionals to be credible and when a person is perceived to be credible, then an 
individual may be less apt to ask questions pertaining to his or her medications. 
Credibility-enhancing actions from the prescriber can include highlighting qualifications, 
providers showing that they care about the other person, being assertive, and highlighting 
sources of information.  
According to belief bias (Anandakumar, Connaughton, Coltheart  & Langdon 
2017), people tend to accept all things that fit within their beliefs. For example, if 
individuals believe that doctors are knowledgeable and medications fix things, then 
individual may not challenge the doctor or ask questions.  
Nature of the Study 
A phenomenological study was used in the study. Phenomenologists focus on 
people’s lived experiences and common meanings or threads of the participants. 
Phenomenological scholars explore the thoughts and feelings of the participant’s lived 
experience. I wished to understand the participants’ lived experiences surrounding their 
understanding of their medications, interactions, side effects, and purpose for use while 
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taking numerous medications for multiple ailments. I was the primary collector of the 
data through interviewing, as well as observing individuals, while they communicated 
with me. 
Operational Definitions 
Adults: Individuals between the ages of 19 and 64.   
Adverse drug event (ADE): Injuries resulting from drug-related medical 
interventions (Kohn, Corrigan, & Donaldson, 2000). Injuries can be defined as falls with 
personal injury to body, losing consciousness, and seizures  
Adverse drug reactions (ADR): Any noxious undesired and unintended drug 
effect (Kohn et al., 2000). 
Health literacy: The degree to which individuals have the capacity to obtain, 
process, and understand information about basic health and services available to make 
decisions (DiPiro et al., 2014). 
Medication error (ME): Problems that arise during the process of medicine use 
regardless of their associated outcomes (World Health Organization, 2016).  
Medication-related problem (MRP): Event or circumstance involving drug 
therapy that actually or potentially interferes with the desired health outcome 
(Wolstenholme, 2011). MRP has three subgroups including ADEs, adverse drug 
reactions (ADR), and medication errors (ME).   
Multimorbidity: Cooccurrence of two or more chronic conditions (Guthrie, 
Makubate, Hernandez-Santiago, & Dreischulte, 2015). 
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Polypharmacy: The use of five or more medications by a patient. According to Kukreja, 
Kalra, Shah, and Shrivastava (2013), psychiatric polypharmacy is described as taking five 
or more medications at a time. 
Assumptions, Limitations, Scope, and Delimitations 
Limitations to the study included that the participants were within a small 
geographic location and not representative of the large population of individuals being 
treated with polypharmacy. Access to adults between the ages of 19 and 64 may have 
been a limitation as individuals may not feel comfortable disclosing how many 
medications they are on and what they are taking them for.  
I assumed that the participants would answer openly and honestly to the 
questions. Phenomenological inquiry may not provide the descriptions similar to 
quantitative studies concerning polypharmacy. The qualitative method could be a 
limitation as the data are more subjective information than objective due to individuals’ 
perceptions of their lived experience. Quantitative studies have been able to identify 
issues surrounding the elderly and polypharmacy as well as polypharmacy within the 
population of individuals who are challenged with schizophrenia and other illnesses, such 
as cancer patients, AIDS/HIV patients, and cardiac patients. This study’s findings were 
limited to interpretation rather than to quantitative analysis. 
Significance of the Study 
The significant increase in adverse drug events, emergency room visits, and even death of 
individuals due to polypharmacy is high (CDC, 2012). With the majority of past studies 
focusing on the elderly population, it is unclear how polypharmacy affects the population 
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of individuals between the ages of 19 and 64, and it is unclear what level of 
understanding these individuals have regarding risks associated with polypharmacy and 
what their lived experience has been while taking numerous medications. The study 
findings may lead to positive social change by focusing on the gap of knowledge and 
understanding of individuals between the ages of 19 and 64 who have been prescribed 
five or more medications. These findings could lead to awareness and change in the way 
they approach their care provider about medications. Also, the results may bring a 
different level of awareness to the individual who can ask questions or inquire in a 
different way to professionals who may then decide to consider other alternatives to 
multiple medication prescribing. Individuals could benefit from individual 
psychoeducation, especially during additions or deletions of medications from their 
medication regimens. Alternatively, individuals who are already be aware of the risks 
associated with polypharmacy may interact with their provider in a positive way. 
Summary of Chapter One 
Adults are more at risk of experiencing ADEs due to the amounts of medications 
that individuals are being prescribed by physicians and psychiatrists (Smith-Marsh, 
2016). The purpose of this study was to explore individuals’ understanding of the risks 
associated with taking five or more medications for psychological or physical illnesses 
and ailments. Individuals who take five or more medications have a greater risk of injury 
or an ADE. However, scholars have not explored the population of individuals between 
the ages of 19-64 and their understanding regarding the concoction of medications they 
are on. The conceptual framework that was used for the purpose of this study was that of 
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game theory, credibility theory, and belief bias. This framework assists with 
understanding how the interactions between the prescribing practitioner and the patient 
impacts the outcomes of treatment with relation to medications. By understanding the 
beliefs of the patients and their interactions with their provider, we begin to understand 
their lived experiences with polypharmacy and their understanding of the risks associated 
with their medications.   
In Chapter 2,  I outlined the literature review which provides a framework for this 
study, theories that were used including game theory in regard to the relationship between 
the physician and the patient and their shared responsibility in decision making pertaining 
to treatment. I also examined paternalism and autonomy with regard to the relationship 
between the patient and the physician, credibility theory and belief bias.  
In chapter 3 I explain the research rationale.as well as the design and my role as a 
researcher, recruitment and selection of participants. Detailed analysis of the data is also 
provided in this chapter as well as any ethical treatment and trustworthiness were also 
addressed. Chapter 4 includes all details about the participants and their responses to the 
questions. Included in chapter 5 is the interpretation of the data that was collected and 
findings from the semi-structured interviews, recommendations as well as the limitations 
of the study and implications for social change.  
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Chapter 2: Review of Literature 
Introduction 
Many people rely upon medications to treat ailments, decrease symptoms, and 
manage both their mental health and physical health (CDC, 2014). Arnold (2015) focused 
on the significance of polypharmacy within the elderly population and indicated that 
polypharmacy contributes to the morbidity of elderly individuals. This is one of many 
scholars who have found the correlation between polypharmacy and morbidity. There is a 
gap in the research surrounding individuals within the age group of age 19-64,  as the 
majority of the research has been conducted with elderly participants or record reviews 
looking primarily at the elderly population. The review of the literature includes the 
parameters surrounding the search strategy used and the significance of polypharmacy 
within different age populations of individuals. In this literature review, I will focus on 
the research on the challenges regarding polypharmacy and the effects that polypharmacy 
has on individuals. This will provide a better understanding of the scope of the issues 
surrounding polypharmacy within the aforementioned age group, individual’s knowledge 
of the risks associated with polypharmacy, and the negative or positive effects of being 
prescribed numerous medications could contribute to a person’s overall wellness and 
quality of life. 
Major Section Preview 
The search terms used to find sources for this dissertation included polypharmacy, ADEs, 
MEs, ADRs, adults, medication related problems, health, and medication literacy. I used 
different EBSCO databases to gather peer-reviewed articles and abstracts, including 
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PsycArticles, PsycINFO, PsycBooks, PsycCritiques, and PsycEXTRA. To collect 
additional information, I broadened my search to include the Medline medical database; 
ProQuest Nursing and Allied Health database; and the CINAHL, MEDLINE, and 
Cochrane database. I searched for full text, peer-reviewed articles between the years of 
2010 and 2016 with participants between the ages of 19-44 and 45-64. I identified a total 
of 84 journal articles out of 5,744 total articles found after narrowing the search by 
adding criteria. Out of the 84 articles, only seven directly related to the topic of this 
dissertation. 
Review of Literature 
There can be risks associated with taking five or more medications for different 
ailments. The risks identified include drug-drug interactions, significant side effects, 
hospitalizations, and death (CDC, 2012;Eyoh, 2016). In the following literature review, I 
provide insight into individuals’ understanding regarding the risks associated with taking 
five or more medications; individuals’ medication literacy; and individuals’ perception of 
their role in the medical, mental health, and pharmacologic decision making.  
Polypharmacy  
Polypharmacy has become the standard norm due to the increase of individuals 
with multimorbidity (Guthrie et al., 2015). The use of multiple medications has become 
the typical treatment for all ailments. According to Guthrie et al. (2015), polypharmacy is 
described as the use of five or more medications; individuals taking 10 or more 
medications has been termed as major polypharmacy. The amount of medication is noted 
to fluctuate within different studies, and there is not a precise definition of polypharmacy 
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being five medications or 10 medications. Individuals prescribed and taking five or more 
different kinds of medications may experience adverse effects. Prescribed medications 
can be of benefit and successful at treating numerous conditions; however, it can 
alternatively pose as hazardous.  
Adverse Drug Events 
Guthrie et al. (2015) found that 6.5% of emergency room admissions have been 
caused by ADEs as identified. Prescribing multiple medications to patients is considered 
to be poor prescribing practice, and it can create adverse outcomes such as unplanned 
hospitalizations. In addition, the more medications someone is prescribed, the higher the 
chance of medication nonadherence. Payne, Abel, Avery, Mercer, and Roland (2014) 
examined different age groups regarding polypharmacy and unplanned hospitalizations 
and found that 7.1% of the individuals with one or more unplanned hospitalizations due 
to ADEs were between the ages of 20 and 59. Whereas, Payne et al. found that 8.7% of 
the individuals were between the ages of 60-79. The most common ADEs included falls, 
allergic reactions, unintentional overdoses, and issues from side effects. According to 
Hampton et al. (2014), there were a variety of events that brought individuals to seek 
medical treatment in the emergency departments. For example, movement disorders and 
spasticity were experienced after taking antipsychotics, and confusion and impaired 
consciousness was experienced by some individuals in relation to taking lithium 
(Hampton et al., 2014). In regard to individuals presenting to the emergency department 
for a change in mental status, behavioral and mood changes, as well as impaired 
cognitive functioning, were experienced by individuals taking sedatives and anxiolytics 
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(Hampton et al., 2014). Stimulants and antidepressants had smaller numbers of people 
presenting to the emergency department with adverse events; however, when they did, 
they had complaints of cardiovascular issues and hypersensitivity to the medications 
(Hampton et al., 2014). Al Hamid, Ghaleb, Aljadhey, and Aslanpour (2014) examined 
hospitalizations and found that many of the hospitalizations were due to ADRs focusing 
on the elderly population.  
According to Pedrós et al. (2014), 186 individuals who presented to the urgent 
care presented with ADEs. These individuals were taking multiple medications and had 
negative consequences related to the medications they were taking (Pedrós et al., 
2014).With regard to the elderly population and polypharmacy, Chaipichit, Krska, 
Pratipanawatr, Uchaipichat, and Jarernsiripornkul (2014) explored how individuals 
qualified their ADRs, and they noted that individuals had a difficult time identifying what 
the symptoms were from and how to be able to better assist patients with ADR. 
According to Cardoso, Miasso, Galera, Maia, and Esteves (2011), adherence may play a 
role in adverse drug interactions as well as their knowledge of the benefits and risks.  
Age Group 
 Polypharmacy within the elderly population has been explored as individuals 
within the 65 year and older population have had more negative outcomes than others. 
The negative outcomes described included falls, hospitalizations, and emergency rooms. 
Jones,Tabassum, Zarow, and Ala (2015) found that the noncognitively impaired elderly 
struggled with recall of medical issues, amount of medications, and names of 
prescriptions. If the elderly patients incorrectly reported their medications to their 
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doctors, there could be prescribing issues such as drug-drug interactions. Crofford (1987) 
identified many different challenges with polypharmacy in the elderly. In addition, 
Crofford found that the higher amounts of medications an individual was taking, the 
higher the likelihood there would be ADRs.  
According to Ramaswamy et al. (2011), 12% of elderly individuals were taking at 
least five medications, and 23% of individuals were taking 10 or more medications. In 
addition, doctors were not aware of the potentiality of inappropriate prescribing 
(Ramaswamy et al., 2011). Ramaswamy et al. identified that one of the barriers in 
prescribing numerous medications was the lack of education or training regarding 
prescribing for elderly individuals and numerous medications.  
 Kulkarni et al. (2012) looked at individuals on five or more medications in the 
treatment as usual (TAU) of Bipolar I and schizoaffective disorder with the average age 
of the individuals being 42 in an age range of 18 to 79. After 2 years of following TAU 
within this group, symptoms were managed successfully with polypharmacy in only 84 
individuals and unsuccessfully with 155, indicating that these individuals had a relapse of 
their symptoms within the 2-year time frame (Kulkarni et al., 2012). Kulkarni et al. did 
not focus on ADEs, MEs, or ADRs. Kulkarni et al. did identify that within this 2-year 
time period, 44% of the individuals were hospitalized. The hospitalizations were due to 
symptom nonmanagement, as Kulkarni et al. did not adequately define whether the 
hospitalizations were due to adverse drug events, drug-drug negative interactions, or 
other reasons pertaining to the combination of the medications.  
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Medication and Health Literacy 
 DiPiro et al. (2014) outlined the meaning of health literacy. DiPiro et al. stated 
that health literacy is the capacity an individual has to obtain, process, and understand the 
basic concepts pertaining to health information and services needed to help him or her to 
make appropriate decisions. Zhong, Zheng, Guo, and Luo (2016) found that although 
patients were provided with information about their medications, fewer than 25% of the 
patients were able to recall the side effects of the medications. In addition, Zhong et al. 
found that age and education correlated with the level of an individual’s literacy. For 
example, older individuals had a lower level of literacy, and individuals with a higher 
education level increased their level of medication literacy and understanding.  
Makaryus and Friedman (2005) examined the percentages of individuals who 
could list their medications, had knowledge about their diagnosis, could identify the 
purpose of their medications, and could list the side effects of the medications they were 
discharged on. Makaryus and Friedman indicated that there was a decrease in medication 
literacy in individuals at or after discharge from an inpatient setting. Four to 18 days after 
individuals were discharged, only 56% of individuals were knowledgeable about the 
dosages of their newly prescribed medications at discharge, and only 11% of the 
participants were aware of the side effects or adverse effects the newly prescribed 
medications could have (Maniaci, Heckman, & Dawson, 2005).  
The level of knowledge an individual has about his or her health and his or her 
medications is considered to be a person’s health or medication literacy level. According 
to Serper et al. (2013), individuals thought that their primary care physician knew more 
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about all of their medications than they did. Individuals may get a false sense of security 
with that thought process. The patient’s perception was that the health care provider had 
greater knowledge than the patient, and the patient did not question the provider.  
Theoretical and Conceptual Framework 
According to a qualitative study that was informed by game theory, the authors 
were looking at the role or interactions between the individual decision makers such as 
the patient and the physician and specifically looked at physicians and patients each 
playing a role in the decision making (Tarrant, Dixon-Woods, Colman, Stokes 2010). If 
the patient has a higher level of trust in the provider, then they may allow more of the 
decision making to be done by the provider and if not the patient would play more of a 
role in the pharmacological decision-making as well as overall care. There are different 
principles that providers follow that would limit the decision making or autonomy of a 
patient to include that of harm, paternalism, legal moralism, and welfare. This is also 
important to take into consideration as even though the patient may want to play more of 
a role in the decision making regarding their mental, physical health care, the provider 
may believe that it is in the best interest of the patient to make the choices they do.  
According to Loignon and Boudreault-Fournier (2012), their review of research 
focused on individual’s participation in decisions and the care they gave or received. The 
research showed the most common models included that of patient choice and 
paternalism. Historically, paternalism is seen as a provider’s portion of the decision 
making as dominant and subordinate. According to Murgic et al (2015), the literature 
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reviewed thus far shows that more providers are giving patient’s a decision making role 
in their medical care than in previous decades.  
With all of the frameworks collectively reviewed, individuals either have a choice 
in their care or they do not have a choice and the provider/prescriber may be directive. In 
addition, if patient’s believe that their practitioner is expert and more knowledgeable than 
they are, then they may give the decision making over to the practitioner and may be less 
likely to ask them questions about their prescriptions and overall care. 
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Chapter 3: Research Methods 
Introduction 
Scholars have examined the issues that have been surrounding polypharmacy with 
a main focus on the elderly population. There are minimal studies on younger 
individuals, such as those between the ages of 19-64. In this chapter, I outline the 
qualitative method that was used to assist in understanding the participants’ personal 
experiences with polypharmacy. In addition, the participants’ understanding of the risks 
and benefits of the medications and their experiences with their prescribing physician and 
level of comfort with asking questions of the professionals was also addressed. 
Research Design and Rationale 
Research Methodology 
Qualitative methodology was selected to study polypharmacy within the 19-64 
year age group. Due to the lack of qualitative investigations of this age population, it was 
difficult to predict what the findings would show. In regard to polypharmacy within the 
elderly population, there are a large number of quantitative studies identifying variables 
to measure among a large number of elderly individuals.   According to Creswell (2009) 
and Patton (2002), qualitative inquiry is nonuniform, yet captures diverse perspectives on 
a particular topic. I collected data from individual interviews with participants, 
observations, and documents to assist with building patterns and themes from the 
information gathered 
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Research Design 
 A qualitative approach for this study assisted in a better understanding of what 
people are aware of when taking multiple medications. Phenomenology is one of the 
qualitative designs used to explore the participants’ lived experience, and it takes into 
consideration their subjective viewpoint of what it means to them. Phenomenology was 
used to bring life to the participants’ lived experiences of being prescribed five or more 
medications by the same or different physicians. In exploration of a person’s lived 
experience in research, I can begin to understand or make sense of their thoughts, 
feelings, perception, and description.  
Participants of the Study 
The participants consisted of a total of eight individuals selected from a 
convenience sample who were prescribed and were taking five or more medications for 
different ailments albeit mental health or any physical health conditions. The participants 
must have been prescribed five or more medications, live in a small Midwestern city, and 
were within the 19-64 year-old age range. The CDC (2012) suggested that there have 
been issues surrounding polypharmacy including ADEs, ADRs, and MEs resulting in 
emergency room visits, hospitalizations, and falls. The participants included both men 
and women who had been prescribed or were taking five or more medications daily.    
Research Questions 
 
1. What is the lived experience of adults who are prescribed five or more 
medications?  
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2. What is the knowledge of medications and understanding of risks associated with 
medications? 
3. What are the participants’ ability and comfort in asking prescribers questions 
pertaining to their medications?   
Ethical Protection of Participants 
The participants in this study were adult volunteers between the ages of 19 and 
64. There was no more than a minimal risk associated with participating in this study. If a 
participant experienced harm or difficulty associated with participating in this study, a 
referral to services or resources in the community, such as mental health professionals, 
primary care physicians, or crisis services, was made. Each participant completed a 
consent form, and confidentiality was protected.  Files including informed consent and 
consent to voice record, digital voice recordings, and transcripts will be stored in a locked 
cabinet in my home office. Only I had access to the transcripts. Identifying information 
was removed from transcripts prior to data validation. In addition, participants were 
assigned an alphanumeric code to maintain confidentiality.  
Procedures 
 
The following procedures served as a sequential guide to recruit and inform 
participants, collect and analyze data, and validate findings. Participants were recruited 
through a flyer/handout that was placed and the office of the Public Housing Authority in 
a small Midwestern city.  
1. After gaining approval from the IRB at Walden and the administration of the 
Public Housing Authority in a small midwestern city, I placed an information 
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packet about the research in the office of a small Midwestern City Housing 
Authority including my contact information for those individuals who were 
interested in participating to be able to reach me and leave a message or e-mail.  
2. I scheduled informative phone calls with the interested individuals and gained 
basic information to make sure the individual fits the required criteria of 
participants in the study (age between 19-64 and taking five or more 
medications). 
3. I contacted the participants during the specified time agreed upon and set up a 
time and place to complete the interview and complete the consent required. 
Conducting an interview in the participant’s home was only approvable if (a) a 
neutral, private location is also offered as an alternative such 
as reserving the community room or library at the different housing buildings or 
giving an option for a conference room at a local coffee house (Java Vino) or 
library; or private office space (b) my presence would not expose the participant 
or family to any risks; (c) extra provisions were made to ensure privacy during the 
interview; and (d) extra provisions were made to ensure that I was not imposing 
on the family by letting the interview run long, staying beyond my 
welcome. Therefore, I used a timer or soft alarm to assist with time awareness and 
setting stopping times as well to do check-ins with participants.   
4. During the individual interview, each participant was given a copy of the letter 
describing the study and was asked to sign the consent form/consent to voice 
record form. The interview also included asking questions listed in the interview 
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protocol and concluded with asking the participants if they had any other pieces 
of information to add. 
5. I transcribed digital audio recordings  verbatim and analyzed the data using the 
NVivo program to identify themes. I took notes as well.  
6. I validated themes and similar terms extracted from transcribed audio recordings 
about their experiences and written observations and notes. Hermeneutics was 
used to interpret the text. This interpretation were assisted with NVivo software to 
find common themes within the rich texts.  
Data Collection 
Data were collected through the means of one interview that took approximately 
1-2 hours. In the first part of the interview, I focused on background information of the 
participant with the main purpose of putting the participant’s experience into context. 
This interview involved building rapport, signing the consent form, and gathering 
information about the individual’s life experience related to being prescribed and taking 
five or more medications for different ailments. Information gathered during the 
interview provided insight into the level of knowledge the participants had about their 
medications and the associated risks, if any. In addition, the demographics of the 
participant were collected as well including age, number of medications, education level, 
and natural support system. Also in the interview, the participant was informed of the 
nature of the study and my personal family experiences related to possible risks and 
benefits related to being prescribed numerous medications.   
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I asked focused questions that stemmed from the research questions in this study 
(Appendix B). Each participant was asked to answer interview questions to address the 
research questions. Each question for the second interview is listed in Appendix B. 
Additionally, the questions served to validate the overall meaning for the group of 
participants discovered during the analysis of data.    
The interviews were conducted in my residence or an available conference room 
in the human services building, whichever was more comfortable and selected by the 
participant that was free from distraction and private. Additionally, notes were taken to 
document any nonverbal communication and to provide details of the environment. Data 
were organized by creating files of the transcribed interviews. Files and recordings will 
be maintained in a locked filing cabinet in my home office in addition to having 
information in a password-protected file on my personal laptop at home. Once the data 
were transcribed, the process of analyzing the information began.  
Data Analysis 
Once the data were organized, I obtained an overall understanding of what type of 
information the data provided through use of coding for themes. After data collection, I 
transcribed the interviews. Reading each transcript in its entirety and gaining a general 
sense of the information provided was the initial step in gaining a better understanding of 
the meaning of the participants’ reported experience. The goal of this initial step was to 
understand what types of information the data conveyed.  
The subsequent step was to begin by highlighting and listing statements identified 
in the text that had relevance to the phenomenon being studied. In this case, I extracted 
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statements to understand how individuals within the particular age group understand their 
medications and the risks and benefits of taking their medications for the conditions in 
which they were prescribed them. In addition, statements of commonality were identified 
on their feelings, descriptions, and perceptions of their relationship to taking medications 
and approachability of their provider.   
I then labeled the statements to understand the phenomenon of individuals taking 
five or more medications experiences. For the study, I identified any patterns or themes 
from the transcripts of the audio recorded interviews. These expressions represented the 
knowledge of medications, the connection and comfort level of their prescribers, and 
their lived experiences of any adverse drug issues in regard to the participants’ 
experiences of the phenomenon. The statements were reframed by using psychological 
meanings to describe the everyday, ordinary language concerning the phenomenon.          
The final step was to analyze the data, which involved developing individual descriptions 
of the participant’s personal experience. Constructing what it means for each participant 
to be on five or more medications was a part of the descriptive explanation of the 
individual interview. The descriptive explanation incorporated all aspects of the 
individual interview. 
Verification of Findings 
The research findings were verified instead of validated, which is common in 
qualitative studies. Verification of the findings keeps the integrity of qualitative inquiry 
intact (Creswell, 1998). The process of verifying the findings entailed at least two of 
eight recommended steps. Creswell (1998) recommended that the researcher use 
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procedures that comprise either “persistent observation, triangulation, peer review, 
negative case analysis, clarifying researcher bias, member checks, rich and thick 
description, or external audits” (pp. 201-203).   
Clarification of researcher bias was important in this study. The reader needs to 
understand the researcher’s position in relation to the topic (Creswell, 2009). I had many 
family members and friends, as well as clients, who experienced polypharmacy in 
different ways. Many of the individuals that I had experience with had, in some way, 
been impacted by the use of five or more medications and some with a lower level of 
understanding of the interactions of different medications. To minimize this bias, I had a 
peer reviewer assist in identification of presence of bias.  
The final form of verification stemmed from having a rich description of the 
participant’s experience. Detailed description “allows the readers to transfer information 
to other settings and to determine whether the findings can be transferred based on shared 
characteristics” (Creswell, 1998, p. 203). This study included verbatim transcripts 
providing contextual and descriptive information. Each of the aforementioned methods of 
analysis was important in providing a rich description.   
Summary 
 In this chapter, the methodology that I chose was outlined. The rational for 
selecting the individuals was also outlined, in addition to the instrumentation and 
protocol used to analyze the data. Ethical protection of the participants was also 
described.  
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Chapter 4 includes details about the population chosen; the sample size; the data 
collection and data analysis; and the procedures, themes, and the results including quotes 
and observations. 
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Chapter 4: Results 
Introduction 
The purpose of this qualitative study was to explore the lived experiences of 
community dwelling individuals between the ages of 19-64 who were taking five or more 
medications. Particularly, I wished to know if individuals were aware of the risks 
associated with taking five or more medications including side effects and drug-drug 
interactions and what the challenges were, if any, associated with polypharmacy. 
Furthermore, it was important to know the participants’ ability and comfort in asking 
prescribers questions pertaining to their medications. The questions that were asked of 
each participant are included in Appendix B. I used NVivo software to manage the study 
data and to assist in the analysis. I used NVivo to sort the interview data into common 
words and phrases, which facilitated the development of themes in the coding process. 
Three research questions were used to guide the study: 
1. What is the lived experience of adults who are prescribed five or more 
medications?”  
2. What is the knowledge of medications and understanding of risks associated with 
medications? 
3. What are one’s ability and comfort in asking prescriber’s questions pertaining to 
their medications?   
I will present the results of the analysis of the study data in this chapter. I will 
describe the setting and different conditions that may have influenced the participants or 
their experience at the time while answering the questions and sharing their lived 
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experiences. In addition, Chapter 4 includes the description of the demographics of the 
participants including their age, gender, and how many medications they have been 
taking, whether prescribed or over the counter, and number of prescribers they had. I also 
present the results of asking the participants a series of questions for the qualitative study. 
Data collection and analysis will be outlined and themes identified. Evidence of 
trustworthiness and the results will be shared, including credibility, transferability, 
dependability, and confirmability as well as my observations and a summary.  
Research Setting 
In this study, I applied the convenience sampling strategy where I displayed a 
flyer at the eight different subsidized housing units in a small, Midwestern city to gain 
volunteer participants for the study. Interested individuals were asked to contact me via 
telephone or e-mail if they were between the ages of 19-64 and taking five or more 
medications. They were given choices as to where the interview would take place. Three 
of the eight participants asked to meet with me at an office in the downtown area of the 
small Midwestern city for confidentiality purposes. Two participants asked for me to 
meet with them in their apartment, and three participants asked that I meet with them in 
the community room at their housing complex where we could meet in confidentiality. 
One of the interviews in the community room had a lot of background noise; however, 
the participant was accepting of this and was not distracted by the background noise in 
the hallway.  
After approval from the IRB from Walden University, flyers were displayed at the eight 
different subsidized housing complexes, and interested individuals left voicemails for me 
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expressing their interest. Interview times and places were then set up for each of the 
participants. Each participant received an informed consent form that included the study 
description, along with the expectations of the process for the study for the participant 
(see Appendix C). The participants were asked to complete the consent form in person, 
and I gave them the choice of reading it themselves or having me read it to them prior to 
signing, indicating their agreement to voluntarily participate in the study. The in-depth 
interviews were semistructured, which allowed for the participants to share their 
experiences and describe their understanding of any risks associated with polypharmacy. 
In this study, I collected data from interviews with the participants. I used the same 
interview protocol for all interviews. After an introductory greeting, I asked the 
participants whether they would agree to be recorded. All participants agreed to being 
recorded. I then approached each interview with the questions that are outlined in 
Appendix B and also identified later in this chapter. 
Data Collection 
The participants were assured that their identity would be confidential and were 
given alphanumeric codes to identify them in the study. Data were collected through the 
means of one interview that took on average approximately 1 hour. In the interview, I 
focused on background information of the participant with the main purpose of putting 
the participants’ experience into context. This interview involved building rapport, 
signing the consent form, and gathering information about the participants’ lived 
experience related to being prescribed and taking five or more medications for different 
ailments. Information gathered during the interview provided insight into the level of 
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knowledge the participants had about their medications and the associated risks of the 
medications, if any. In addition, demographics of the participant were collected, 
including age and number of medications. Also, in the interview the participants were 
informed of the nature of the study and experiences related to possible risks and benefits 
related to being prescribed numerous medications.   
I asked a series of focused questions outlined in the research questions in this 
study (Appendix B). Each participant was asked to answer interview questions to address 
the research questions. Additionally, the questions served to validate the overall meaning 
for the group of participants discovered during the analysis of data. Each participant was 
given an informed consent to read or I gave them the option of having me read it to them 
prior to signing it.   
The interviews were conducted in the participant’s residence or an available conference 
room in the building, whichever was more comfortable and selected by the participant 
that was be free from distraction to ensure privacy for the participant.. Additionally, notes 
were taken to document any nonverbal communication and to provide details of the 
environment. Data were organized by creating files of the transcribed interviews. Files 
and recordings have been maintained in a locked filing cabinet in my home office, in 
addition to having information in a password-protected file on my personal laptop at 
home. The data were transcribed, and each transcript was reviewed numerous times to 
gain an in-depth understanding of the participants’ lived experiences. 
Data Analysis 
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As previously mentioned, I assigned alphanumeric identifiers to each of the 
participants to assure participant confidentiality, and face to face semi-structured 
interviews were completed. Interviews took place in a space of the participant’s choosing, 
and I transcribed the interviews verbatim. Each transcript was read by me in its entirety 
and I reviewed my field notes which contained my observations, reflections, and insights 
to gain a better understanding of the meaning of the participants’ reported lived 
experience.   
Next I highlighted and listed statements identified in the text that had relevance to 
the phenomenon being studied.  In this case, I extracted statements to understand how 
individuals within this particular age group understood their medications and the risks 
and benefits of taking their medications for the conditions in which they were prescribed 
them. In addition, statements of commonality were identified on their feelings, 
descriptions, and perceptions of their relationship to taking medications and their 
perception of the approachability of their provider.   
Labeling  the statements identified as necessary to understanding the phenomenon 
of individuals taking five or more medications.  For this study, I began to identify 
patterns and themes from the transcripts of the audio recorded interviews. These 
expressions represent the knowledge of medications, the connection and comfort level 
with their prescribers, and their lived experiences of any negative or positive outcomes in 
regard to the participant’s experienced of the phenomenon.  The statements were 
reframed by using psychological meanings to describe the everyday ordinary language 
concerning the phenomenon.          
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Finally, analysis of the data took place, which involves developing individual 
descriptions of the participant’s personal experience with the use of NVivo 12. I inputted 
and arranged the transcripts into subfolders that identified, sorted and arranged the data. 
This assisted in the development of themes with regard to the participant’s lived 
experience and coded for participant’s personal experienced commonalities. I continued 
data analysis until data was saturated.   
Evidence of Trustworthiness 
 There are four components of trustworthiness including credibility, transferability, 
dependability, and confirmability. In relation to qualitative research, valid and reliable 
instruments are not used for data collection and therefore it is absolutely pertinent that the 
researcher addresses trustworthiness in regard to their research through assessing the 
aforementioned components of trustworthiness (Creswell 2014).  
Credibility 
 The quality of a phenomenologic qualitative study is significantly important to 
contribute to the knowledge in the area of clinical psychology as well as related to 
polypharmacy. Triangulation is one of the main ways to check for credibility in one’s 
research. Triangulation is asking the same questions of the different participants, 
collecting data from different sources and also different methods used to ask research 
questions (Dye, Rosenberg, & Coleman 2000).  
In addition, I was aware of and transparent with regard to personal biases related 
to the topic regarding polypharmacy. Reflecting on my viewpoint to clarify my biases is 
an important part of being credible. I employed a systematic procedure during the 
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interview process. By asking all of the participants the same line of open ended questions 
in a semi-structured interview style, it added to the credibility of the study.  
Transferability 
 Trustworthiness of transferability relates to external validity. Whether the 
research has the ability to be generalized, and if it can be used in different contexts and 
situations.  According to Creswell (2009), there are eight strategies that are primary 
related to transferability. For the purpose of this study, I used detailed and rich 
description. Detailed description of the participants and the demographics were included 
so that the study can be duplicated in the future. The detailed descriptions ensure 
transferability by transporting the reader to the environment and also give the discussion 
a bit of shared experience.   
Dependability 
To ensure dependability, adherence to the quality standards and guidelines 
outlined by Walden University was done. Particularly, the guidelines followed included 
the Form and Style Review Checklist as well as the Dissertation Checklist, and the 
Dissertation Minimum Standards Rubric. Furthermore, the engagement of the dissertation 
chair and committee with incorporation of any recommendations or suggestions was 
utilized to ensure a dependable research study. With regards to the study and the 
participants, the research study and the environment with which it was conducted was 
described in totality. Interviews were conducted in-person. Each of these methods were 
used to ensure the study results can be viewed as a dependable addition to knowledge 
base in the area of polypharmacy and psychology.  
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Confirmability 
 Trustworthiness as it relates to confirmability is the level of confidence that the 
findings of the research are based on the participant’s narratives instead of on the 
researchers’ biases. Phenomenology focuses on one’s lived experiences and common 
meanings or threads of the participants. Unlike quantitative research, qualitative 
phenomenological design explores the thoughts and feelings of the participant’s  lived 
experience (Creswell 2014). By recording the topics that were unique in the study, 
identifying themes and coding, one is completing an audit trail which is one of the 
techniques used to prove confirmability. 
Demographics 
Inclusion criteria for the study reflected the following sample characteristics: all 
eligible participants were both males or females between the ages of 19-64. In addition, 
they were all community dwelling individuals in public city housing in a small 
midwestern city. All eight disclosed that they were taking five or more medications. Also,  
the participants were not pregnant and were not a resident in any facility such as jails or 
prisons, nursing homes, mental health facilities and were not classified as elderly. I 
interviewed eight participants face to face,  1 male and 7 females. The individuals 
interviewed were in the ages ranging from 28-62 years of age with the average age of 
49.5. A summary of each participant’s experience follows the table.  
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Table 1 
Demographics 
 
Participants Identifier Age Gender     # of 
Providers 
# of 
Medications 
      
      
1 MM001 62 F 4 15 
1 MM002 62 F 8 22 
1  MM003 38 F 2 11 
1 MM004 53 F 4 15 
1 MM005 52 F 4 13 
      
1 MM006 28 F 3 10 
1 MM007 53 F 4 10 
1 MM008 53 M 2 15 
Note: N=8 
Background 
Interview Questions 
 The interview questions posed were to answer the three research questions 
through exploration of  the participant’s knowledge and understanding of the medications 
in which they were prescribed and taking on a daily basis, their knowledge and 
understanding of the risks, if any, and the comfort level they have with their prescribing 
practitioner. The following interview questions set the foundation for answering the 
research questions.  
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Interview Question 1: The first question was a two part question where the 
beginning asked for demographics and the second part of the question asked specifics of 
the demographics. “ Please tell me how many medications you are currently taking 
(prescribed and over the counter)? Please tell me the names of your medications and the 
reasons why you take those medications”.  
The answers to the first part of the question is depicted in Appendix D identifying 
how many medications each participant is taking. The second part of the question related 
to the participants ability to name the medications and share the reason for taking them to 
get a better understanding of what the participants were aware of with regard to the name 
and reason for taking the medications. Seven out of the eight participants referred to a list 
of their prescriptions in front of them with the dosages, the names of the prescriptions, 
and the reason for taking them and the timing of taking the medications. The participants 
identified that if they did not have that in front of them they would 1) not remember all of 
the medications or 2) their specific reason for taking all of the medications.  
The participant that is 28 years of age (MM007) and on 10 medications with four 
being over the counter and six being prescribed did not refer to a list of their medications 
and was able to recall the purpose for taking all of the medications. The least amount of 
medications taken by participants is 10 different medications and the most is 22 different 
medications. A listing of the medications individuals were prescribed is outlined below as 
well as the purposes for taking the medications and the potential for certain drug 
interactions as outlined on a website specializing in drug-drug interaction identification.  
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MM001 shared: I was prescribed the following medications: cholecalciferol, 
clonazepam, Epinephrine, Glucagon, Glargine, Levothyroxine, Lisinopril, naproxen, 
Omega-3, potassium chloride, prazosin, pyridoxine, Quetiapine, aripiprazole. She also 
shared that she has some pain issues, diabetes mellitus, as well as issues with anxiety and 
seizures. She also shared that she has been on these medications for the past 17 years.  
MM002 stated while looking at a list on her online record on her phone: 
 “I am on the following medications”: Doxepin, Omeprazole, Fluoxetine, 
Gabapentin, cyclobenzaprine, Naproxen, hydroxyzine, PEG electrolytes, lamotrigine, 
lisinopril, lidocaine, and amitriptyline. She shared that she has been taking medications 
for a while, since the late 1990s, but in the past two years she has been on five or more 
medications. While looking at the list, she states “it doesn’t say here what they are for, 
but I think the amitriptyline and lidocaine I think are for pain”, lisinopril is for heart, nope 
blood pressure, lamotrigine is a mood stabilizer, the PEG thing that is if I am not regular 
which hardly ever happens. Hydroxyzine is pain, so is the Naproxen and the 
cyclobenzaprine. The gabapentin is for what they describe as “periodic limb movements 
of sleep”, it happens even if I am awake. The fluoxetine is ah, depression, and 
omeprazole heartburn acid reflux. Doxepin is another one that is for depression and 
anxiety all that, so…” 
MM003 shared that she was prescribed the following medications:  
Phenhydromine, Diphenhydramine, Amoxicillin, ascorbic acid, aspirin, 
buspirone, calcium, carbadilol, Zyrtec, Penlac, Benadryl, Flonase, Lasix, 
Furosemide, clonazepam, Gabapentin/Lidocaine/Amitriptyline cream, albuterol, 
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levothyroxine, potassium, metformin, Zyprexa, Lyrica and Omeprazole. 
Amoxicillin and that is an antibiotic used before any procedures due to heart 
issues, ascorbic acid Vitamin C, I take vitamins, aspirin since my heart surgery, 
buspirone, I take it for depression, and calcium, and carboxy… I use for my eyes, 
Zyrtec allergies, carbadilol, I think it says on the sheet for my heart. Penlac is for 
my nails, Benadryl is for insomnia or nasal congestion. Furosemide, and Lasix, 
that is for fluid retention and heart failure. Clonazepam is for my mental health, 
and the Gabapentin/Lidocaine/Amitriptyline cream I use for pain. The 
levo…albuterol is an inhaler I use for wheezing or when I am sick, and the 
levothyroxine is used for thyroid and stated “I don’t know if I am under thyroid or 
over thyroid”. Potassium is for heart, and metformin… “That’s for um they called 
it pre-diabetes but now they call it glucose intolerance”. Zyprexa is main on for 
mental health. Lyrica is for neuropathy, “I have like back pain and leg pain and a 
lot of different pains and they are hoping that the Lyrica will even that out. 
Because right now I think they are calling it fibromyalgia”,  and omeprazole is for 
heart burn.  
MM004 
 This participant shared that they were on the following medications: losartan, 
omeprazole, haloperidol, pravastatin, Januvia, levothyroxine, lorazepam, and Imitrex. 
I’ve got low thyroid, that is what the Losartan is for, I’ve got high blood pressure, high 
cholesterol, diabetes and acid reflux and I take the omeprazole for acid reflux.”  
MM005 
39 
 
 
 This participant shared that they are prescribed baclofen, Effexor, Keppra, 
carbamazepine, simvastatin, loperamide, levothyroxine, and Botox injections. 6-7 
medications; Baclofen 10 mg 3 x daily; vagus stimulator-seizure activity; Effexor 375 
mg-depression; Keppra 500 mg 3 tabs am and 3 tabs night seizures; Carbamazepine 
(Tegretol) 300 mg + 200 mg seizures, Simvastatin 20 mg daily cholesterol; loperamide 
for diarrhea-wears diapers,  Botox injection in arm for muscles; Levothyroxine 10 mcg 
“but I don’t remember what it is for”. 
MM006 
 This participant reports taking Adderall, Xanax, Metoprolol, naproxen, trazodone, 
bupropion, Symbicort, Magnesium sulfate, Zyrtec, and levothyroxine. 15 meds 
prescribed and over the counter. Unsure of what she is on and needs to look on phone on 
her on-line record. Adderall 10 mg 2 x and prn 25 mg as needed; Xanax 0.5 mg as 
needed/scheduled-anxiety; Metoprolol tartrate 25 mg 2 in a.m. and 2 in p.m. for blood 
pressure and thickening of heart wall; Naproxen/Aleve; protonix; Trazodone 2 (50) for 
sleep; buproprion 450 mg for depression; Symbicort inhalant for asthma; magnesium 
500/day; Zyrtec for allergies, calcium, vit D3, Flonase; Levothyroxine (Synthroid) for 
thyroid-antidepressant (?), and calcium.  
MM007 
 This participant is prescribed Viibryd, Latuda, prazosin, clonazepam, lidocaine 
two kinds, and naproxen and over the counter medications such as Tylenol and ibuprofen. 
At least five prescriptions and then over the counter medications. Viibryd is for 
depression, Latuda for bipolar; Prazosin for night terrors “which doesn’t work but I take 
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it”; Clonazepam for anxiety; Lidocaine patches, salve, and cream for back pain; nicotine 
gum for smoking cessation; Naproxen as an anti-inflammatory as well as Tylenol and 
Ibuprofen for inflammation and pain; Fiber and an over the counter deep tissue rub.  
MM008 
 This participant shared that he is prescribed Celebrex or celecoxib, Ritalin, 
Latuda, lorazepam, omeprazole, metformin, fish oil, Chantix, Lyrica, albuterol, and 
Wellbutrin (bupropion). About 10 medications;  Celoxib (Celebrex) is for depression, 
Ritalin, Latuda-depression or bipolar, Lorazepam-sleep aid, Lisinopril, Omeprazole, 
Metformin-diabetes, Curcumin-anti-inflammatory, fish oil, vitamin c, multivitamin, 
Chantix-smoking cessation, Lyrica, Albuterol inhaler for respiratory, Wellbutrin for 
weight loss; was on pain medications four times per day for last 14 years and went off of 
them 6 weeks ago. 
Interview Question 2 
The second question that was asked of the participants was, “How many different  
 
doctors do you work with that prescribe these medications?” This question is part of the  
 
demographics and details are outlined in Appendix C. This question was asked as part of 
trying to understand if all of the medications prescribed were from one 
provider/practitioner or if there were more than one practitioners. This interview question 
assists with answering the second research question related to the risks of being on five or 
more medications.  
Interview Question 3: The third question asked of participants was, “How would you 
describe your overall health since you have been taking the medications?”  
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The primary theme that emerged from the question was that of their quality of life 
is poor, fair or better with the majority of individuals describing their current overall 
health as fair to poor.  
Participant MM001 indicated: “ I wouldn’t say I was healthy, Not good, not good. Still 
having 70 percent of symptoms while taking the medication”. 
Participant MM002: “Physically no, I don’t feel physically better or healthier”. 
Participant MM003: “Fair, fair, because the medications are what keeps me going.I’m 
stable”. 
Participant MM004: “Fair, it could be better”. 
Participant MM005: “Poor, tired all of the time, falls have increased due to the 
medications that relax muscles; I have to wear diapers due to diarrhea and incontinence. 
Memory is poor, focus is hard”. 
Participant MM006: “Overall Mental health in many ways is better now than previously 
but also more clear and aware when I am having problems. I felt more numbed, mentally 
numbed where, just the therapy is helping. I better understood why what and doing 
something to change that and in the past seeing someone just to see someone. I think 
when I started getting into recovery it was about that same time, like I have some control 
in my health and just taking what the doctor says”.  
Participant MM007: “Overall wellness and health rate as a 70 out of a 0-100 scale for 
quality of life per se. Some medications do not work. Prazosin is supposed to take away 
night terrors and it does not. Pain is not managed”. 
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Participant MM008: “Overall health poorer than previous when was not on medications. 
Feels more down, somewhat. Began medications in 2003. Quality of life on a 0-100 scale 
is 25 at present”. 
Interview Question 4: “How confident are you in your prescribing doctor and what level 
do you feel as if they understand you?  
The theme that arose were those of higher trust versus lower trust that they are 
heard by their doctors or feel understood by their providers. This was quite interesting as 
all of the participants have numerous providers and seven out of the eight participants are 
trusting of their providers and on numerous medications that do not work well all of the 
time to improve their overall health.  
 
Participant MM001 shared “I have major issues with one of the medical entities in 
town, I told them I had that and it did not work and they said maybe it’ll work this time 
you know it was a complete nightmare for a full year. My foot doctor does understand me 
and I trust him, Dr. Powell does, and my diabetes doctor does, but not sure my regular 
doctor does”. 
Participant MM002: “Um, as far as prescribing medicines, I feel as if it is their first and 
their go to and like let’s not figure this out and let’s put you on something to see if this 
figures it out and helps. The other day I went in and she said I don’t have a magic pill. I 
don’t want a magic pill, I just want answers. That’s all I have ever wanted is answers. I 
am so sick of pills. But I do need the omeprazole that much I do know in life”. 
Additionally, “I think I feel heard but not listened to. Um, she is really not empathetic, I 
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have noticed that”. “Um I trust her” and then later she stated “I can ask her questions but 
I am not sure I will get a full answer”.  
Participant MM003: “I do basically I trust them all except I need a different pain pill 
because the one I am on doesn’t work”.  
Participant MM004: “Yes, doctors are pretty open and they listen”.  
Participant MM005: “Minimally. I think they understand me now but not sure about my 
new doctor yet as she is new. I am frustrated”.  
Participant MM006: “I really like doctors now; I really like her (GP) feel very confident 
working with her. She prints things out and talks things out. Trust my psychiatrist and 
nurses will get back to me”.  
Participant MM007: “The doctors I have now I feel as if they understand me more than 
previously. The last 13 doctors did not understand me”.  
Participant MM008: “APNP/psychiatrist I am confident that they understand me but 
unsure of others at this point. APNP did Genesight testing to help get me the best 
medications. Two that did not show on there I continue to take because I do not want to 
go off”.  
 
Interview Question 5: “Please tell me what you know about the risks and side effects  
 
of taking the prescribed medications that you are on?”  
 
 This question posed to be quite interesting in that the main themes identified for 
individuals being on 10-22 medications were drowsiness, or that they were given a sheet 
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of paper with the side effects and risks outlined however no one was really aware of the 
risks or the possible interactions or side effects of all of their medications.  
Participant MM001: “Well you always get, you know you get a slip when you get 
medications” and “I can’t tell you what all of them are. I know there are risks of taking 
too many medications and interacting with the other”.  
Some drug-drug interactions identified from the drugs.com website as a major 
interaction between potassium and lisinopril which could create significantly high levels 
of potassium in the blood called hyperkalemia which has the potential to lead to kidney 
failure, muscle paralysis, irregular heart rhythm or cardiac arrest. Other potential drug-
drug interactions in reference to the medications this individual is prescribed include that 
of low blood pressure, dizziness or drowsiness, and high blood pressure 
(https://drugs.com/druginteractions.html). 
Participant MM002: “so some can have a drowsy effect” and “or heart feeling funny and 
I know there are so much more but I can’t think of them off the top of my head”.  
The drug-drug interactions that are considered “major” interactions include 
amitriptyline and fluoxetine which can cause sedation, dry mouth, blurred vision, 
constipation, and urinary retention. Interactions between doxepin and fluoxetine which 
cause sedation, dry mouth, blurred vision, constipation and urinary retention as well. The 
next major drug-drug interaction identified is between amitriptyline and cyclobenzaprine 
which has the potential of causing serotonin syndrome with symptoms of confusion, 
hallucination, seizure, extreme changes in blood pressure, increased fever, excessive 
sweating and diarrhea. Severe cases could experience coma or death. It is reported that 
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the combination of doxepin and cyclobenzaprine and also the combination of fluoxetine 
and cyclobenzaprine also have similar drug-drug interactions as the previous. Moderate 
interactions include that of dizziness or drowsiness, confusion, and difficulty 
concentrating and heat intolerance (https://drugs.com/druginteractions.html).  
Participant MM003: “I get it refilled I get a sheet on it. Yeah it is like weight gain, 
sleepiness and tiredness. I know the weight gain, I have gained like, I looked at my driver 
license last time I got it in 2010 I think and I gained at least 50 pounds since then and I 
don’t know if it is side effects of the medications that I have been slowly having to take 
or if it is the way that I am eating”.  
According to the drugs.com drug-drug interaction checker, there are three 
different combinations that have major interactions, including the combinations of 
clonazepam and Zyprexa, Benadryl and potassium chloride, and potassium chloride and 
Zyprexa. The first combination can This can cause low blood pressure, shallow 
breathing, weak pulse, muscle weakness, drowsiness, dizziness and slurred speech. 
Whereas the other two combinations may affect the stomach and upper intestinal tract. 
There are numerous moderate interactions which outline side effects such as dizziness, 
drowsiness, confusion, and difficulty concentrating 
(https://drugs.com/druginteractions.html). 
Participant MM004: “Suicide, Suicide is the risk of the medication, I cannot remember. 
Prolixen was for sure but I don’t know about the haloperidol”. 
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The drug-drug interactions identified that the mixture of these medications could 
cause drowsiness, dizziness, confusion and difficulty concentrating as well as lower one’s 
blood pressure(https://drugs.com/druginteractions.html).  
Participant MM005: “Risks of taking all my medications is that I cannot drink alcohol. It 
is common sense. I believe everyone should have a pharmacologist on their team to help 
with this understanding”.  
 The drug-drug interactions identified from the website included that of weight 
gain, constipation fatigue and low blood pressure when taking carbamazepine and 
levothyroxine conjunctively. In addition, Effexor and Keppra combined as well as 
baclofen and Keppra combined, carbamazepine and Keppra combined, baclofen and 
Effexor, carbamazepine and Effexor, carbamazepine and baclofen in combination, could 
increase side effects of dizziness, drowsiness, confusion and difficulty concentrating 
(https://drugs.com/druginteractions.html). This participant stated that one of the 
challenges she has had in the past included falls which could have been a result of 
dizziness, and she stated that she cannot go back to school or continue her education as 
she has memory issues and concentration issues. Also noted was an interaction of 
carbamazepine and grapefruit or grapefruit juices as this could cause increased levels of 
the carbamazepine. If one becomes toxic of carbamazepine the side effect is drowsiness 
(https://drugs.com/druginteractions.html).  
Participant MM006: “I don’t know, I am given sheet of paper to look at”. I don’t 
typically look at them.  
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According to the drugs.com website, there are major interactions between the 
bupropion and Adderall, the bupropion and trazodone, increasing and individual’s risk 
for seizures at it lower the seizure threshold in an individual. There is a report of 
moderate drug-drug interaction between Xanax and Zyrtec, bupropion and Zyrtec and 
trazodone and Zyrtec, as well as the combination of metoprolol and Xanax, metoprolol 
and trazodone, Xanax and trazodone which increases side effects of dizziness, 
drowsiness, and difficulty concentrating. (https://drugs.com/druginteractions.html). 
Participant MM007: “This is a catch 22. No one knows what the risks or side effects are”.  
Some of these medications do interact and according to Drugs.com website, the 
side effects include dizziness, drowsiness, and confusion. One interaction the medication 
Latuda has is with food. If an individual eats grapefruit, it may increase the blood levels 
of the medication which can increase the risks of high blood sugar, diabetes, seizures, 
abnormal muscle movements, and heat related disorders 
(https://drugs.com/druginteractions.html). 
Participant MM008: “No one has told me about risks of medications other than liver 
damage. The pharmacist just gives the meds and tells when to take and with or without 
food”. 
According to Drugs.com the interactions identified with these medications include 
an increased risk for seizures, increase blood pressure or heart rate, dizziness, confusion, 
and difficulty concentrating. In addition, one interaction the medication Latuda has is 
with food. If an individual eats grapefruit, it may increase the blood levels of the 
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medication which can increase the risks of high blood sugar, diabetes, seizures, abnormal 
muscle movements, and heat related disorders (https://drugs.com/druginteractions.html). 
Interview Question 6 “What was the most challenging aspects of taking five or more  
 
medications daily?”   
 
The theme identified with this question was that individuals have a difficult time  
 
remembering to take their medications regularly. According to Participant MM001 
shared:  
“I’m having a heck of a time keeping them straight because some I take twice per day”.  
And Participant MM002 stated:  “Sometimes I almost forget to take them and ah, 
sometimes, or when I do, I don’t wanna do it. I mean I just kind of coach myself to take 
them”.  
Participant MM003 stated: “I forgot to take it over a period of about six days” and 
“well it would be a problem if….now I get mine bubble packed….. I think that would be 
the most challenging to have to set up my own medications”. She shared that the only 
way she can have the bubble packed medications is if it is funded by her managed care 
organization that she is in and if this program goes away she would be quite worried as 
she would have to figure out a way to set up her own medications.  
Participant MM004 indicated: “ What is challenging for me is picking them up  
(medications) from the pharmacy is hard”. She shared that all of her medications run out 
at different times and she has to make sure to be aware of when her medications are due 
to be refilled. 
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Participant MM005 concluded that the most challenging aspect of being on five or 
more medications is “gets in the way of me learning or educating myself”, as the side 
effects of the medications makes her feel doped up and not able to concentrate or 
remember things.  
Participant MM006 reported: “Taking medications regularly or scheduling is hard 
due to too many, no schedule-sleep hard, picking up meds at pharmacy as they all run out 
at different times”.  
Participant MM007 indicated “ Sometimes I forget medications. I take six pills at 
a time and that is hard. Mental weight; scheduling when to take the medications. In the 
past 3 months have forgotten to take medications three times”.  
Participant MM008 shared: “I have forgotten sometimes. Medications not working”. He 
shared that he struggles with depression and his symptoms are not managed with the 
medications as his pain was not managed by the medications and he went off all of them. 
He stated by going off the pain medications after the first few weeks he is actually feeling 
less pain and wonders if his depression would lift if he went off the other medications but 
he will talk with his prescriber.  
Interview Question 7  “What was the most positive aspects of taking five or more  
 
medications daily?”  
This question was asked of the participants as a balancing question as part of their 
lived experiences with taking five or more medications. I wanted to gain insight into how 
individuals perceived the benefits of takin medications, if any. The responses elicited 
from this question were highly variable. There were no two answers alike.   
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What I found fascinating was that all of the participants involved in the study 
identified very independently unique positive aspects of taking medications. Three out of 
the eight participants described their positive aspects more collectively.  
Such as participant MM003 stated: “Medications allow me to stay in my 
apartment and be independent”. Participant MM004 indicated: “They keep me alive”, and 
participant MM006 said: “Most of my symptoms are managed”.  
The other five participant focused on one set of symptoms that were addressed 
with medications such as participant MM001: “Medications control my insulin”, even 
though this participant is on 15 different medications for different ailments, this was the 
most positive aspect for the participant that was identified. Similarly, others focused on 
individual ailments that were managed such as seizures, mania, heartburn, and successful 
smoking cessation.   
 
Interview Question 8 “Have you had any hospitalizations, falls, adverse reactions to  
 
medications in the past?”  
This question was posed to the participants to hear about their lived experiences 
related to negative aspects of taking five or more medications. I originally thought that it 
would be difficult for the participants to respond to this as it could be difficult to identify 
why one has fallen as there could be many variables however, the following is how the 
participants responded: 
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The theme that arose within this question is that of increased falls since being on 
medications and the second theme found was that of suicidal ideation that the participants 
have experienced taking medications.  
MM001 responded that she was hospitalized “Mostly for mental health reasons, 
suicide attempts and stuff like that, numerous times went to the emergency room and on 
the antibiotics and stuff and C. Diff. and I was severely dehydrated”.  
MM002 reported: “I have had falls but I cannot tell you for certain if it was 
because of the medications”. “And a prescriber at the county put me on Rexulti and that 
gave me a reaction I saw this one doctor, pain doctor and he gave me a cortisone shot and 
I had a reaction to that”.  
MM003 shared: “I forgot to take it (Zyprexa) over a period of about six days and I 
ended up in the hospital and they gave me sublingual Zyprexa every prn to catch up. So 
she was hospitalized for not taking medications, more of a side effect of going off 
medications spontaneously.  
MM004 said: “Yeah, yeah… Yeah I am also an alcoholic too and that is how I 
ended up in there and ended up in there more than once, drinking and taking my 
medications”.  Also, “I was at work and took Xanax I was doing something on a moving 
belt. I felt like I was going to have a heart attack”. “Cephalexin makes me throw up. I 
don’t know what statin does. Steroids, I don’t want steroids as it interacts with 
Haloperidol”.  
MM005 shared: “Yes. I fall a lot. I fell once due to medications relaxing muscles 
too much and drop foot and I broke arm and had to have stay in nursing home. When at 
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the nursing home some idiot gave me Darvocet and I was choking on vomit and needed 
to go to the hospital”. This participant was upset when responding to this question. She 
stated that she still gets angry when she recalls this memory but she is “ok”.  
MM006: Dizziness due to medications, some falls, can’t remember, she has been 
in car accidents when she is not on ADD medications and she becomes distracted. 
Sometimes she has been hospitalized but not in the past 13 years. She has gone to the 
hospital but not admissions. She did fall and break her leg once in the recent past, but she 
is not sure if this is due to medications.  
MM007 reported: “Once I was hospitalized due to becoming suicidal on a new 
medication and they kept me for three or four days and took me off the medication. I 
have falls a lot as when I take all medications at night I become disoriented. (She also 
shared after the recording was turned off that she does drink and smoke marijuana and 
this may interfere with her medications contributing to her falls”).  
MM008 responded to this question and states: “Kidney issues due to not hydrating 
enough with medications and have been hospitalized for this multiple times”.  
 
Interview Question 9:  “Do you believe that there are other treatment options then  
 
medications for your medical or mental health conditions that could be helpful?”  
I asked this question to gain a better understanding of the participant’s perspective 
of possible alternatives if they were able to take less medications. This question was to 
assist with gaining insight into their lived experiences and if they believed that there 
could be alternatives to taking medication that they were not offered previously.  
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MM001 responded that she took a class once and been to a few groups that were 
helpful many years ago however this has not been offered to her currently.  
MM002 shared: “Well I have heard about like ah, I don’t want to say herbal 
remedies but just like ah…folk medicine or like eating one thing might ah…help with 
indigestion or something else might help with….” And expanded with: “Yeah people had 
to get through life before medicine. Ya know they came up with their own stuff, some of 
it wasn’t so great. But um, like one of them was taking in like something horrible, 
something with lead in it or something like that. But I found out something and I don’t 
know if you know this but oh, silver….it’s called colloidal silver, it is supposed to be 
really good for you, I wouldn’t think that drinking a metal would be but apparently it is”. 
MM003 explained: “ Physical therapy, chiropractic, um I’m trying to think. When 
I was with the county way back when they had down at the downtown they had mental 
health groups that I had went to”.  
MM004 shared “Counseling” could help and shared that instead of being put on 
another medication that she is going to grief counseling due to all of the losses she has 
experienced and this is helpful.  
MM005: “Yes, homeopathic treatments I would like to research, pet therapy-
would like a dog, acupuncture I would like to try”. She is looking into this on her own as 
her prescribing providers have not offered her alternatives to medications thus far.  
MM006: WRAP “(Wellness Recovery Action Plan) and Acceptance and 
Commitment Therapy (ACT); EMDR might be helpful. Therapy is good. Mail delivery 
medications”. This participant shared that since she has become educated about herself 
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and her challenges with mental health and physical ailments she knows what is available 
and could be helpful, however providers have not suggested alternatives to her.  
MM007 shares: “Exercise, quit smoking, and medicinal THC would be nice and 
helpful for anxiety, depression, and pain issues”. Her practitioners have suggested to her 
to quit smoking however they have not suggested medicinal marijuana or exercise to her 
knowledge.  
MM008: “Physical knee replacements, shoulder replacements, physical therapy, 
nutritional therapy or dietician, weight loss”. This participant stated that his prescribing 
practitioners have not recommended much of the above except for weight loss as he is 
over 400 pounds.  
Interview Question 10:  “Do you feel as if your doctor is directive (telling you what  
 
medications you need) or gives you a choice (does your doctor ask for your input)?”  
The theme identified with regard to whether individuals perceive they have a 
choice in what medications they are prescribed or if they believe their practitioner to be 
more directive where the participant has less of a choice, was that of their practitioners 
being directive and not giving them a choice. Even though it was identified that seven of 
the eight participants believed that their practitioner was directive and made the 
medication decisions, Participant MM006, the participant that stated that she believed her 
practitioner to give her a more direct role in prescribing stated the following: 
“You don’t have healing unless you have a good relationship with your doctor”, 
and “Dr.White, I really like her”. She still indicated that her doctor made the 
decisions and because she trusted her prescribing practitioner she did not ask any 
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questions of her and believes she has her best interest at heart. She also stated: 
“Doctor gives me a choice and I am an advocate for herself. We were taught to do 
what the doctor says, instead of advocating for self. If I wasn’t recovery oriented 
or trained in self-responsibility or educated then I would just do what the doctor 
says”.  
Participant MM001 stated “No” I don’t get a choice, when I go in and ask or 
make a suggestion they put me on what they want me to be on.  
Participant MM002 shared “She doesn’t ask me”, she just states that she is going 
to put me on a medication and I don’t believe I have a choice. “I don’t know if the 
medication is working”, but I keep taking it.  
Participant MM003 disclosed: “I have been asking him for a different pain pill for 
quite a long time and he keeps giving me the Tramadol”. Indicating that the doctor is 
more directive and in a parental role directing the treatment without discussion of the 
reasoning for not changing medications.  
Participant MM004 indicated: “they talk to me about what they are going to put 
me on”, and she does not ask or get to choose what she is taking. She also shared that she 
trusts her prescribing practitioner and does not question.  
Participant MM005 said: “More directive. Some doctors increase doses of 
medications to shut me up”. “ They don’t listen to me”, “I was at Mayo and they forced 
me to go to Gundersen and I was really angry”, she did not get a say in this per her report.  
Participant MM007 shared: “Directive, I have had to really fight for the 
medications I have right now”.  
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Participant MM008 stated: “They are more educated than I am, more directive, I do not 
have choice”. This statement goes along with belief bias as this participant believes that 
due to their education he has to listen to them as he is less educated and therefore has less 
of a say in his treatment. 
Overall Lived Experiences of Participants 
Participant MM001 
 This participant reported that her health was not particularly better since taking 
five or more medications and her mental health was “not good, not good”. She reported 
that she continues to have 70 percent of her symptoms not managed by the medications 
and has had some significant issues with practitioners in the past where she did not feel 
validated or listened to. She does report a higher level of trust with her specialty 
practitioners however less trust for her primary care practitioner at this point in time. She 
was unclear what the risks were regarding all of the medications she was on and shared 
that “they give me a list at the pharmacy” however she never really looks at the list. This 
participant also shared that she struggles with keeping her medications straight as she 
takes so many and some she takes twice daily. The one medication she finds helpful is 
the one that controls her diabetes. That is the ailment that is most controlled with the 
medications. She shares that the adverse effects of being on all of the medications is 
suicidal ideation which she has experienced. When asked if she felt there was any 
alternative treatments that could be helpful, she shared that a class or group therapy could 
be helpful in managing some of the mental health symptoms instead of the medication. 
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And finally, she shared that she does not believe she gets a choice in her care and that the 
practitioner is more directive in her care and medications.  
Participant MM002 
 In regard to this participant’s lived experience, she shared that being on five or 
more medications has not improved her physical health. She shared that “she feels heard 
but not listened to”  by her practitioner. The difficult thing about being on numerous 
medications is that she forgets to take her medications sometimes. She shared that the 
only side effect she knows off the top of her head is that “some can cause drowsiness”. In 
addition, she shares that one of the medications that does work is the one that controls her 
heartburn. She shared that an adverse effect she experienced was a reaction to a new 
medication that was added to her numerous other medications where she needed to go to 
the emergency room for treatment. Possible alternatives to medications she would like to 
consider is herbal remedies. This participant describes her practitioner as directive and 
does not give her the choice in taking part in her care, and she reports trusting her.  
Participant MM003 
 This participant describes her overall health as being “fair” and reports that 
“medications keep me going”. She shares that she does not know if there are a lot of risks 
associated with all of the medications but that she “gets a sheet” from the pharmacy when 
she gets her medications and that some may cause tiredness. She shares that she has had 
some falls and this could be related to the medications. One difficult thing is organizing 
her medications and taking the right ones and that is why she gets her medications bubble 
packed for ease of dispensing without having to do this herself. She believes that the 
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medications allow her to be able to remain living in her apartment and shares that 
alternatives to medications could be group therapies. She does report trusting her 
practitioner with her care and the decision making and when she tries to give her input on 
what she needs she does not believe that the practitioner listens to her and is more 
directive with her care.  
Participant MM004 
 This participant shared her lived experience and stated that her overall health is 
“fair and could be better”. She does state that she has had an adverse reaction to 
medications and she was hospitalized to take her off of her medication that was causing 
her problems. In addition she states she trusts her practitioners and they are directive and 
tell her what they are going to do with her medications and care. She said the only risk of 
a medication she is taking is risk of suicide and the most difficult thing about taking so 
many medications is picking them up from the pharmacy as sometimes they do not have 
the medications and the different prescriptions run out at different times during the 
month. She believes her medications keep her alive. The only alternative she thinks could 
be helpful in place of some of the medications is counseling.  
 
 
Participant MM005 
 This participant describes her overall health as being poor as she is tired all of the 
time, she has had numerous falls due to her muscles relaxing too much because of the 
medications and she has to wear diapers as she has incontinence issues due to the 
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medications. She is not aware of the risks of taking five or more medications but knows 
she cannot drink alcohol with them. She does not believe her practitioners are credible, 
and believes that they do not listen to her and sometimes “puts me on medications to shut 
me up”. She fell due to the medications and broke her arm and needed to go to a nursing 
home for a period of time to recuperate. The most positive thing about taking some of the 
medications is that she no longer has seizures. So in essence she does not trust her 
doctors and they are more directive and she does not believe that she has a say in her 
care. She does believe an alternative to some medications would be therapies such as pet 
therapy.  
Participant MM006 
 This participant stated that after many years of not being well on medications, her 
overall health is better. She does trust and like her practitioners and she feels as if she has 
a say in her care and treatment. In the past she has had car accidents that were a negative 
outcome to her not taking the medications she was prescribed or taking some of the 
medications and driving. She is not aware of the risks such as side effects or drug-drug 
interactions but states “I get a sheet of paper with those on it”. She identifies that her 
practitioners give her a choice and she advocates for herself and feels it is collaborative 
with regard to decision making. She does believe that some alternatives to medications is 
therapy and mail delivery of her medications would be best as it is difficult for her to pick 
up medications from the pharmacy as they need refilling at different times. She would 
like to be off all her medications someday.  
Participant MM007 
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 This participant shares that her overall health is fair and 70 percent of her 
symptoms are managed currently. She had many years of struggles where she was on 
numerous medications and her symptoms were not managed. She did have an adverse 
reaction to medications and was hospitalized for suicidal ideation and taken off the 
medication. She is not aware of the risks, side effects, or drug-drug interactions stating: 
“This is a catch 22 no one knows what the risks or side effects really are”. She believes 
her practitioners now understand her and she trusts them. She does believe that her 
practitioners are directive and does not give her a choice, nor does she ask questions of 
them. An alternative to medications could be exercise.  
Participant MM008 
This participant shared his lived experience and states his overall health is “poorer on all 
of the medications” then prior to medications. He stated that he does trust one of his 
practitioners and that they are directive and do not give him a choice in the decision 
making related to his care and medications. He stated that he has not been told of the 
risks, side effects,  or drug-drug interactions associated with taking all of his medications. 
He forgets sometimes to take his medications and this elicits a negative outcome for him. 
The medication he knows that has worked is that of a smoking cessation medication as he 
no longer smokes. He has had kidney failure and been hospitalized due to some of his 
medications and needed to be taken off or have medications readjusted. Different 
therapies could be alternatives to medications per his report. When asked the question 
about decision making medically he stated that: “They are more educated than I am, more 
directive, I do not have choice”. 
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Study Results  
The conceptual framework for this study encompassed that of Game Theory, 
Credibility Theory, and Belief Bias. Game Theory looks at the role or interactions 
between the decision makers (Tarrant, Dixon-Woods, Colman, & Stokes 2010). This 
theory is typically used in mathematics however has been tagged in psychology as 
“Social Interaction theory” In this study, the decision makers identified were the 
practitioner of the participant and the participant themselves.  According to the Game 
Theory, the outcome depends on the interaction or collaboration between and choices 
made by the practitioner and the participant/patient.  Adversely, if the patient does not 
have a high level of trust for the physician, then the patient would attempt to play more of 
a role in the pharmacological decision-making as well as their overall care. There are 
different principles that providers follow that would limit the decision making or 
autonomy of a patient to include that of harm, paternalism, legal moralism, and welfare 
(Tarrant, Dixon-Woods, Colman, & Stokes 2010). This is also important to take into 
consideration as the provider may believe that it is in the best interest of the patient to 
make the choices and decisions on behalf of the patient.  
A review of research focused on individual’s participation in decisions and the 
care they gave or received. The most common models in this research included that of 
patient choice or autonomy and paternalism. Paternalism is seen as a provider’s portion 
of the decision making as dominant and subordinate (Loignon & Boudreault-Fournier 
2012). For the purpose of this study, I am researching from the angle of the participants 
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lived experiences related to interaction with their providers and the participants 
experiences with five or more medications.  
 Credibility Theory is another framework that was used in this study. This theory 
focuses on past experiences to predict future events. Therefore, if a patient has 
experiences with a practitioner and they deem them as being credible or trustworthy, then 
they predict that future events or outcomes will be similarly positive.  
 In relation to the belief bias framework, Stephens, Dunn and Hayes (2018) 
connect belief bias and decision making. Specifically that judgements are influenced by 
ones past experiences to come to a conclusion. The belief bias is also called response bias 
and is closely linked to credibility theory as they both take into consideration one’s past 
experiences to influence the decision making in a certain situation or circumstance.  
Summary 
In Chapter 4, the findings from the face to face interviews with the voluntary 
participants were presented. The participants shared their personal perspectives on their 
lived experiences in the phenomenological study to help with a better understanding of 
their experience being on five or more medications and also shared their understanding 
and knowledge of the risks associated with practicing polypharmacy. Analysis of the data 
identified themes with regards to their knowledge. The themes that surfaced from the 
analysis of the participant’s narratives identified their personal descriptions of their 
experiences while taking five or more medications, including their level of knowledge 
and understanding of the risks and benefits of taking medications, their connection with 
their practitioners who were prescribing the medications and their perspective of the 
63 
 
 
outcomes of their care. The research questions were answered based on their narratives 
and the emergent themes.  
Chapter 5 further addresses the content and answers to the research questions that 
were asked of the participants. Interpretation of the data with identification of the key 
findings, limitations of the study as well as recommendations for further research being 
outlined and implications for social change addressed. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Discussion 
According Masnoon et al. (2017), the most common way of reporting 
polypharmacy was through a numerical context. Typically, medications are prescribed to 
individuals to optimize health outcomes with those who have multimorbidity. Individuals 
who are prescribed more medications have an increased chance of ADEs, ultimately 
causing harm although the intent was to optimize patient’s health (CDC, 2012).  
This phenomenological study was done using open-ended questions to explore the 
level of knowledge the participants had regarding their lived experience with taking five 
or more medications, the risks and benefits of their medications, their comfort level with 
their practitioner, and the type of relationship and interaction style they had with their 
practitioner. Despite the research on polypharmacy, there was a gap on a certain 
population of individuals, as well as focusing on a person’s lived experiences in relation 
to polypharmacy. To fill the gap in literature, it was important to focus on individuals 
between the ages of 19-64 and their understanding of the risks associated with taking five 
or more medications as this has not been explored.  
I also explored what individuals know about taking five or more medications and 
what the challenges are associated with polypharmacy. By hearing about individuals’ 
thoughts and feelings and knowledge associated with their experience of taking five or 
more medications, I had a better understanding of what is needed to help people be more 
aware of their medications, interactions, and adverse effects of being on five or more 
medications. 
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Interpretation of Findings  
The results of this qualitative study assists in filling the gap within the literature 
related to polypharmacy and individuals’ understanding of the risks associated with it. In 
regards to the first research question, I found that all participants did not know all of the 
possible risks, side effects, or drug-drug interactions of their medications. In addition, 
although many reported not liking having to take so many medications, they continued to 
take the medications without asking questions. Furthermore, seven of the eight 
participants did not know their medications or what they all of them were used to treat 
without referring to a printout of the medications provided by their practitioner or the 
pharmacist. All participants described that their prescribing practitioners were more 
directive with their care; however, one participant connected with her prescriber and 
liked her as a person; she perceived this prescribing practitioner as someone who would 
give her choice when in actuality she did not have a choice.  
The study results support the theoretical framework of game theory where both 
the prescribing practitioner and the participant worked in conjunction with one another 
for the acquired outcome. Seven out of the eight participants responded that more 
paternalism on the prescribing practitioner’s part was used where they did not feel as if 
they had a choice pertaining to their care. One individual believed that he or she did have 
a choice in his or her care due to his or her belief that the practitioner was credible, 
likeable, and had similar interests as the participant. The conceptual frameworks of 
credibility theory and belief bias also played a role. The participant who perceived her 
practitioner as credible asked fewer questions of the provider and believed his or her 
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practitioner would only do what was in their best interest. The other participants believed 
that their providers were less credible; however, their belief was that prescribing 
practitioners would not prescribe them medications that were not needed, and because the 
prescribing practitioners were educated more than the participant, the participant assumed 
that the prescriber knew what they were doing and did not feel comfortable asking 
questions. 
Limitations of the Study 
 There were limitations to this study. This study was completed/conducted with 
individuals between the ages of 19-64 who resided in a small Midwest city within the 
subsidized housing complexes. This was a small subsection of the population as a whole. 
Although the subsidized housing units were minimally culturally diverse, future scholars 
would benefit from having a more diverse population to pull from.  
Another limitation to this study was that of unbalanced gender participation. This 
subpopulation of individuals who took part in the study were primarily female. There was 
only one male who agreed to being interviewed for this study, and seven females agreed 
to take part in the interview. Future studies would be improved if the gender was more 
balanced male-female.  
Pertaining to assumptions, it was assumed that the participants would answer 
openly and honestly to the questions presented by the interviewer. Phenomenological 
inquiry may not provide the descriptions similar to previous quantitative studies 
concerning polypharmacy. Also, some of the participants stated that they do not think 
their practitioners know what they are doing; however, even out of the eight stated that 
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they trust their practitioners. By completing a qualitative study, a scholar could see the 
limitation to this as being more subjective information than objective due to individual 
perception of their lived experience. 
Recommendations 
 There are many individuals who are taking and being prescribed numerous 
medications. It is recommended that further research focus on this age group of 
individuals either qualitatively or quantitatively. Future studies with this age group in 
different parts of the county or country may be well informed about the medications they 
are taking in regard to the risks including drug-drug interactions and side effects of the 
medications. Additionally, it would be interesting to better understand individuals’ 
perception of the relationship they have with their prescribing practitioner and their 
perception of the prescribing practitioner knowledge and relate it to perception of 
credibility and individuals’ belief of prescribers in regard to their care.  
Implications of Social Change 
The results of this study could prove to be beneficial to many different groups of 
individuals in understanding the risks of numerous medications and also sharing with 
others the right to choice of treatment about their care and the medications that they are 
putting in their body.  
This study could be used as a resource for many, including individuals, 
practitioners who prescribe, and education systems. Individuals can begin to understand 
the interactions between themselves and their prescribers, explore what their perceptions 
and beliefs are, and begin to understand that they have a right to ask questions about their 
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medications even though they may be less educated than the prescribing practitioner. 
Prescribing practitioners can begin to understand their role and whether or not they are 
parental in their responses or can assist with their patients’ choice in their care to 
prescribe or deprescribe. With regard to the education system such as universities and 
colleges, this study could be useful for individuals going into the field of medicine or 
prescribing to better understand giving patients a choice, allowing others to ask questions, 
and understanding the importance of informing the patient about their medications that 
are being prescribed related to the risks and benefits. Furthermore, this could be a 
resource for advocacy groups and patient advocates at clinics and hospitals to assist 
patients with gaining knowledge of their medications including both the risks and 
benefits and assisting individuals with communicating with their providers for a better 
understanding to minimize ADEs and to assist patients with taking part in informed 
decision making with regard to their medications.  
Conclusion  
Discoveries or findings engendered from this phenomenological research assist 
with closing the gap within the present literature through descriptions of participants’ 
lived experiences with taking five or more medications and the knowledge of the risks 
associated with this as described by the eight participants between the ages of 19-64. I 
found that there was a lack of knowledge of the risks associated with taking medications, 
especially five or more medications taken conjunctively. 
The research questions assisted with gaining a better understanding of the 
participants’ understanding of taking five or more medications, how this has impacted 
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their lives, and their understanding of the risks associated with polypharmacy. One of the 
main themes recognized was that although individuals were prescribed five or more 
medications, they did not know the risks associated with all of the medications, but rather 
they stated one or two different risks or side effects of one of their medications. In 
addition, although they received printouts of the risks and side effects, none of the 
individuals have read the printouts outlining the risks or benefits.   
I have known many individuals who have trusted their prescribing practitioners 
without asking questions regarding their medications and who have had adverse reactions 
to medications including falls, motor vehicle accidents, and impairment related to daily 
functioning. I wanted to better understand others’ lived experiences regarding five or 
more medications. I learned what they thought were positive contributions of being on 
the medications that they were prescribed and also learned what alternatives they were 
open to trying that have not been offered recently to them including group or individual 
therapy, pet therapy, acupuncture, essential oils, and plant derived natural supplements. 
Future researcher needs to be conducted on assisting individuals with understanding they 
have a voice in their medical and mental health care regarding their medications and 
alternative treatments to minimize ADEs, improve understanding of the risks associated 
with polypharmacy, and improve communication between practitioners and their patients. 
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Appendix A: Interview Protocol 
 
 
Date:____________________________ 
 
Location:_________________________ 
 
Name of 
Interviewer:_______________________________________________________ 
 
Name of 
Interviewee:_______________________________________________________ 
 
Interview Number:  One  
Duration: ______________ hrs/minutes 
 
 
1.  Please tell me how many medications you are currently taking (prescribed and over 
the counter)? Please tell me the names of your medications and the reasons why you take 
those medications. 
 
 
 
 
 
 
2.  How many different doctors do you work with that prescribe these medications? 
 
 
 
 
 
 
3.  How would you describe your overall health since you have been taking the 
medications? 
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4.  How confident are you in your prescribing doctor and what level do you feel as if they 
understand you? 
 
 
5.  Please tell me what you know about the risks and side effects of taking the prescribed 
medications that you are on? 
 
 
 
 
 
6. What was the most challenging aspects of taking five or more medications daily?  
 
 
 
 
 
7. What was the most positive aspects of taking five or more medications daily? 
 
 
 
 
 
8.Have you had any hospitalizations, falls, adverse reactions to medications in the past?  
 
 
 
 
9.Do you believe that there are other treatment options then medications for your medical 
or mental health conditions that could be helpful? 
 
 
10 (There may be more questions to ask, such as follow up questions depending on the 
answer to their previously asked questions). Do you feel as if your doctor is directive 
(telling you what medications you need) or gives you a choice (or does your doctor ask 
for your input)? 
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Appendix B: Demographic Information 
 
Table 1 
 
Participants Identifier Age Gender     # of 
Providers 
# of 
Medications 
      
1 MM001 62 F 4 15 
1 MM002 62 F 8 22 
1  MM003 38 F 2 11 
1 MM004 53 F 4 15 
1 MM005 52 F 4 13 
      
1 MM006 28 F 3 10 
1 MM007 53 F 4 10 
1 MM008 53 M 2 15 
Note: N=8 
